Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3

Published:2015-12 Issue:50 Volume:290 Page:30018-30029
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Ahmed Mahiuddin,Cheng Ming,Zhao Qi,Goldgur Yehuda,Cheal Sarah M.,Guo Hong-Fen,Larson Steven M.,Cheung Nai-Kong V.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference65 articles.

1. Cancer immunotherapy comes of age;Mellman;Nature,2011

2. Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity;Topalian;Curr. Opin. Immunol,2012

3. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N. Engl. J. Med,2012

4. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med,2012

5. Preclinical characterization of 1–7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells;Romagné;Blood,2009

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration;International Immunopharmacology;2024-05

2. From standard therapies to monoclonal antibodies and immune checkpoint inhibitors – an update for reconstructive surgeons on common oncological cases;Frontiers in Immunology;2024-04-23

3. Development of a Human B7-H3-Specific Antibody with Activity against Colorectal Cancer Cells through a Synthetic Nanobody Library;Bioengineering;2024-04-15

4. B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01

5. Targeting Histone 3 Variants Epigenetic Landscape and Inhibitory Immune Checkpoints: An Option for Paediatric Brain Tumours Therapy;Current Neuropharmacology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3